16 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
pHoenix ISE Reagents FOR Olympus AU Chemistry Systems
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Midway Select
FDA UDI
MIDWAY DENTAL SUPPLY, LLC·10843717101878·Burs FG 6, Pkg/100
ORTHOPEDIC MANUAL SURGICAL INSTRUMENT
FDA UDI
FX SOLUTIONS·03701037314326·K-WIRE CENTER GUIDE Ø48 mm
N/A
FDA UDI
BIOMET MICROFIXATION, INC·00841036019358·
Merit Medical®
FDA UDI
Merit Medical Systems, Inc.·00884450157497·
Merit Medical®
FDA UDI
Merit Medical Systems, Inc.·00884450157732·
NA
FDA UDI
STRYKER CORPORATION·04546540756169·5MM FEMORAL REAMER 3-FLUTED
RGP MULTI-PURPOSE SOLUTION ID 100136
FDA 510(k)
FDA Class 2
·Ophthalmic
ELECSYS HCG TEST SYSTEM
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Logical G-Series Cup Shell - Multi Hole
FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215094539·
FREESTYLE FREEDOM
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE INC.·Product code LFR·May 25, 2007
NON AC-POWERED PATIENT LIFT
FDA Adverse Event
Malfunction
·INVACARE SUZHOU·Product code FSA·March 25, 2013
2.5MM DRILL BIT/QC/GOLD/110MM
FDA Adverse Event
Injury
·SYNTHES MONUMENT·Product code HWE·March 7, 2011
Daig Livewire Steerable, Product Number 401905; REPROCESSED ELECTROPHYSIOLOGY CATHETER
FDA Enforcement
Class II
·Ongoing·Stryker Sustainability Solutions·May 20, 2026
Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.
FDA Enforcement
Class II
·Terminated·Belmont Instrument Corporation·October 24, 2012
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014